Page last updated: 2024-08-26

desethylamiodarone and Liver Neoplasms

desethylamiodarone has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanniman, EA; McCarthy, TC; Pollak, PT; Sinal, CJ1
Bakker, O; Hudig, F; Meijssen, S; Wiersinga, WM1

Other Studies

2 other study(ies) available for desethylamiodarone and Liver Neoplasms

ArticleYear
Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:3

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Glucose; Blotting, Northern; Body Weight; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Hepatocytes; Hepatomegaly; Homeostasis; Lipid Metabolism; Liver; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR alpha; Transcriptional Activation

2004
Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene.
    Biochemical and biophysical research communications, 1998, Aug-19, Volume: 249, Issue:2

    Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Hepatocellular; Gene Expression; Humans; Liver Neoplasms; Promoter Regions, Genetic; Receptors, LDL; Receptors, Thyroid Hormone; Transfection; Triiodothyronine; Tumor Cells, Cultured

1998